ZURICH, Oct 25, 2022 (BSS/AFP) - Swiss pharmaceutical giant Novartis reported
a 43 percent drop in net profits in the third quarter to nearly $1.6 billion,
weighed down by the cost of restructuring.

The group's turnover fell by four percent to $12.5 billion on the strength of
the US dollar, but rose by four percent in local currency, it said in a
statement.